Leap offers a range of services, including test preparation (IELTS, TOEFL, SAT), admissions and visa counseling, and ...

Baird analyst Joel Beatty revised the rating on Leap Therapeutics (NASDAQ:LPTX) stock, moving from Outperform to Neutral. This adjustment comes alongside a significant reduction in the price target, ...

Azimuth Renewables, a full-service solar energy development company, appointed Robert L. Scheuermann, CPA, CFA, as its chief ...

Consumer confidence fell this month mainly on a “softer” jobs market, according to LPL Financial Chief Economist Jeffrey Roach. An index of consumer confidence fell in January for a second straight ...

Leap Therapeutics, Inc.'s DKN-01 trial results show mixed outcomes in cancer treatment, prompting potential future funding ...

LPL and Wintrust Financial Corporation signed an agreement in February 2024. On January 25, about $15 billion of brokerage and advisory assets were onboarded to LPL. The remaining $1 billion of assets ...

LPL Financial, a subsidiary of LPL Financial (LPLA), announced that Wintrust Financial Corporation (WTFC) has transitioned support of the ...

CAMBRIDGE, Mass. - Leap Therapeutics, Inc. (NASDAQ:LPTX), a clinical-stage biotech company with a market capitalization of $86 million and an overall "Fair" financial health rating according to ...